Cancer Second Opinion in Gurugram
Asking for a second opinion is a normal and reasonable part of cancer care, not a challenge to your existing doctor. A cancer diagnosis often requires decisions that are difficult to reverse, and it is sensible to be confident in the plan before starting.
When a second opinion is worth seeking
It is worth seeking when the diagnosis is unclear, when the recommended treatment is high risk or irreversible, when you have been told nothing more can be done, when a rare cancer is involved, or simply when you want reassurance before starting a long course of treatment.
What is reviewed
A meaningful second opinion goes back to the source material: the biopsy and histopathology report, immunohistochemistry, molecular testing where done, staging scans, and prior treatment records. The diagnosis and stage are re-examined before any comment is made on the treatment plan.
What to bring
Please carry the biopsy and histopathology report, all imaging including PET-CT or CECT films and reports, blood test results, a list of current medicines, and a summary of any treatment already received with dates.
What you can expect to leave with
A clear statement of what the diagnosis and stage appear to be, whether the proposed plan is consistent with current evidence, what alternatives exist, and what the realistic goals of treatment are. If the original plan is sound, you will be told exactly that.
Consulting for second opinion in Gurugram
Dr. Sandeep Ramawat consults at the American Oncology Institute, Aarvy Healthcare Super Specialty Hospital, Sector 90, Gurugram. OPD hours are Monday to Saturday, 9:00 am - 6:00 pm. Please bring your biopsy report, imaging and any prior treatment records to the first visit.
Appointments: +91 95606 83949 · drsandeepramawat@gmail.com
Frequently asked questions
Most oncologists consider a second opinion entirely reasonable and many suggest it themselves. It is a routine part of cancer care worldwide, particularly before starting an intensive or irreversible treatment.
Usually not. Existing reports and scans are reviewed first. Repeat testing is advised only where something essential is missing, such as molecular profiling that has not yet been done, or where a report is unclear.
Sometimes it confirms the original plan, which is a useful outcome in itself. In other cases it identifies a different subtype, a missed molecular target, or an alternative approach worth considering.
Speak to Dr. Ramawat
Consultations at the American Oncology Institute, Gurugram. Call directly or send your details on WhatsApp.